Anti-covid vaccine for the age group 5-11, the first data will arrive in the autumn “in order to understand if the positive benefit-risk ratio remains valid”. This was explained by Marco Cavaleri, head of Vaccines and Therapeutic Products for Covid-19 of the European Medicines Agency Ema, answering a question at a press conference.
Read also
As for adolescents who can already be immunized, the expert confirmed as “positive the benefit-risk ratio of the two anti-Covid mRna vaccines”, namely Pfizer / BioNTech and Moderna, “which are authorized for use from 12 years of age. upward”.
!function(f,b,e,v,n,t,s)
{if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};
if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;
n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t,s)}(window, document,’script’,
‘https://connect.facebook.net/en_US/fbevents.js’);
fbq(‘init’, ‘415374439673532’);
fbq(‘track’, ‘PageView’);
Read Also
- Delta variant, four nurses already vaccinated with double dose infected Jul 9, 2021
- The debate over the origin of covid-19 is rekindled by a new US report. May 28, 2021
- Pfizer vaccine, “effective in the age group 5-11 years at lower doses” Sep 20, 2021
- Covid Italia, Pregliasco: “Autumn? Quiet with limited red areas” Jul 5, 2021
- Coronavirus infections spike again in Spain Jul 3, 2021
- Quirónsalud Marbella Hospital signs a collaboration agreement with CEPYME Jun 3, 2021
- Maculopathy, with drugs only 6-8% of patients lose their sight Jul 2, 2021
